Company Monitoring Page for BeiGene

latest headlines for company on cafepharma

BeiGene, Brii and Ideaya ring in 2025 with deal news, betting billions in biobucks on prospects
Fierce Biotech
Thu, 01/2/25 - 11:28 am
Tags:
BeiGene, Brii Biosciences, IDEAYA Biosciences, biobucks, antibody-drug conjugates
BeiGene inks $150M deal to follow cancer combo trail blazed by Amgen and Ideaya
Fierce Biotech
Fri, 12/13/24 - 11:41 am
Tags:
BeiGene, CSPC Zhongqi, Amgen, SYH2039, solid tumors
Say goodbye to BeiGene as the oncology biopharma becomes BeOne Medicines in rebrand
Fierce Pharma
Thu, 11/14/24 - 11:06 am
Tags:
BeiGene, BeOne Medicines, rebranding, branding
BeiGene, ex-AstraZeneca exec faces investigation in China: reports
Fierce Pharma
Fri, 10/25/24 - 11:40 am
Tags:
BeiGene, China, AstraZeneca
AbbVie sues rival BeiGene over alleged theft of cancer therapy secrets
Reuters
Tue, 09/10/24 - 09:15 am
Tags:
AbbVie, BeiGene, trade secrets, legal
FDA weighs limiting PD-1 drugs in stomach cancer, calls on experts to discuss Merck, BMS and BeiGene meds
Fierce Pharma
Fri, 08/23/24 - 10:55 am
Tags:
FDA, stomach cancer, Bristol Myers Squibb, Opdivo, Yervoy, Merck, Keytruda, BeiGene, Tevimbra
BeiGene debuts $800M biologics plant set to create ‘hundreds’ of jobs in New Jersey
Fierce Pharma
Tue, 07/23/24 - 06:33 pm
Tags:
BeiGene, biologics, R&D, drug manufacturing, hirings, New Jersey
[podcast]Brukinsa approval raises BeiGene’s hematology profile
Medical Marketing and Media
Wed, 03/20/24 - 09:38 pm
Tags:
BeiGene, Brukinsa, FDA, hematology
FDA approves expanded use of BeiGene's blood cancer drug
Reuters
Thu, 03/7/24 - 05:30 pm
Tags:
BeiGene, FDA, Brukinsa, Gazyva
BeiGene Inks Potential $1.3B Deal with Ensem for Early-Stage CDK2 Inhibitor
BioSpace
Tue, 11/21/23 - 11:54 am
Tags:
BeiGene, Ensem, EXT-197, cancer
BeiGene to go solo with cancer drug after Novartis deal termination
Yahoo/Reuters
Tue, 09/19/23 - 10:30 am
Tags:
BeiGene, Novartis, cancer, tislelizumab, Tivimbra
Bristol Myers, BeiGene end legacy Celgene deal with settlement years after China ban
Fierce Pharma
Thu, 08/3/23 - 11:22 am
Tags:
Bristol Myers Squibb, BeiGene, Celgene
Novartis retreats from TIGIT, handing $300M candidate back to BeiGene
Fierce Biotech
Tue, 07/11/23 - 10:22 am
Tags:
Novartis, anti-TIGIT, BeiGene
AbbVie's Imbruvica-Brukinsa patent suit may have merit, and BeiGene will likely settle: expert
Fierce Pharma
Tue, 06/27/23 - 10:21 pm
Tags:
AbbVie, patents, BeiGene, legal, Btk inhibitors
AbbVie sues BeiGene over brand-new Imbruvica patent as blood cancer rivalry heats up
Fierce Pharma
Fri, 06/16/23 - 09:44 am
Tags:
AbbVie, Pharmacyclics, BeiGene, Brukinsa, patents, Imbruvica, blood cancer
BeiGene's gastric cancer drug succeeds in late-stage trial
Reuters
Thu, 04/20/23 - 11:41 am
Tags:
BeiGene, gastric cancer, clinical trials, tislelizumab
BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint
NJ Business
Wed, 03/22/23 - 11:12 am
Tags:
BeiGene, New Jersey, R&D, drug manufacturing
BeiGene pulls out of Leap of faith, letting option on immuno-oncology candidate lapse
Fierce Biotech
Fri, 03/17/23 - 09:55 am
Tags:
BeiGene, immuno-oncology, Leap Therapeutics, DKN-01
Big Pharma regained ‘mojo’ last year, but biotech valuations remain ‘precarious’: report
Fierce Biotech
Sun, 03/5/23 - 03:06 pm
Tags:
Big Pharma, Novo Nordisk, Moderna Therapeutics, Gilead Sciences, BeiGene
BeiGene doubles sales as Brukinsa, tislelizumab gear up for key launches
Fierce Pharma
Mon, 02/27/23 - 07:06 pm
Tags:
BeiGene, Brukinsa, earnings, tislelizumab

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.